December, 2017 SMM-171
Amazon’s invasion
It’s no good being alarmed about Amazon entering the pharma market as a new channel. The organisation is incredibly competitive; and the disruption it has caused in every market it has touched is a business phenomenon. It would be naive to discount the threat of Amazon – strategists in the life science sector need to understand and address the implications of Amazon’s entry.